SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Wells Fargo Maintains Overweight on ShockWave Medical, Raises Price Target to $46

Wells Fargo maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and raises the price target from $43 to $46.

Benzinga · 05/13/2020 12:44

Wells Fargo maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and raises the price target from $43 to $46.